Stephan Turner in Singularity Hub:
AI company OpenAI and biotech company Ginkgo Bioworks announced in February 2026 that OpenAI’s flagship model GPT-5 had autonomously designed and run 36,000 biological experiments. It did this through a robotic cloud laboratory, a facility where automated equipment controlled remotely by computers carries out experiments. The AI model proposed study designs, and robots carried them out and fed the data back to the model for the next round. Humans set the goal, and the machines did much of the work in the lab, cutting the cost of producing a desired protein by 40 percent.
This is programmable biology: designing biological components on a computer and building them in the physical world, with AI closing the loop.
More here.
Enjoying the content on 3QD? Help keep us going by donating now.